NCT04266912 2025-11-25Avelumab and M6620 for the Treatment of DDR Deficient Metastatic or Unresectable Solid TumorsM.D. Anderson Cancer CenterPhase 1/2 Active not recruiting23 enrolled 11 charts
NCT02595931 2025-11-17M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryNational Cancer Institute (NCI)Phase 1 Active not recruiting66 enrolled